CTSD and neuroblastoma: In order to examine CTSD variants in neural-like cells, a CTSD knockout (KO) was established in human neuroblastoma (SH-SY5Y) and neuroglioma (H4) cell lines by CRISPR/Cas9 technology (Supplementary Figures 1A,B).